Sponsored Content

Monkfruit – natural, sweet and finally approved by the FSA

9 Jul 2024

In a significant regulatory update, the UK’s Food Standards Agency (FSA) has announced that monk fruit, particularly in its non-selective aqueous decoction form, is no longer considered a novel food. This landmark decision came after an extensive review prompted by evidence submitted by Monk Fruit Corp., showcasing the safety and traditional use of monk fruit.

Monkfruit – natural, sweet and finally approved by the FSA
Image courtesy of Van Wankum Ingredients

Background and Implications

Monk fruit, known for its natural sweetness and low-calorie properties, has been used in traditional Chinese medicine for centuries. However, its use as a food ingredient in the UK was previously restricted under the European Union’s novel food regulations, which require a comprehensive safety assessment for foods not widely consumed in the EU before May 1997. The FSA’s new ruling liberates monk fruit from these constraints, allowing its incorporation into a wider range of food and beverage products in the UK without the need for prior authorization.

This regulatory shift reflects a growing trend towards accepting traditional and naturally derived ingredients, aligning with consumer demand for healthier and more natural food options. The decision is expected to have a ripple effect, encouraging innovation in product formulation among UK manufacturers.

Industry Response

The food industry has welcomed the FSA’s decision with enthusiasm. Monk Fruit Corp., the leading advocate for this change, expressed optimism about the potential growth and adoption of monk fruit as a mainstream sweetener. “This ruling is a breakthrough for both manufacturers and consumers,” stated a spokesperson from the company. “It not only provides an opportunity to reduce sugar intake but also supports the development of healthier food products.”

UK food manufacturers are now poised to explore the benefits of monk fruit in various applications, from beverages to baked goods. The ingredient’s high sweetness intensity, coupled with its low-calorie content, makes it an attractive alternative to traditional sugars and artificial sweeteners.

Potential EU Implications

While the FSA’s decision applies solely to the UK, it could influence future regulatory considerations within the European Union. As the EU continues to navigate post-Brexit regulatory landscapes, the acceptance of monk fruit in the UK may prompt a re-evaluation of its status within EU member states. This could lead to a broader acceptance and harmonization of regulations concerning naturally derived sweeteners.

Conclusion

The FSA’s ruling on monk fruit marks a pivotal moment for the food industry, opening doors to innovation and healthier product offerings. As consumers increasingly seek natural and low-calorie alternatives, the acceptance of monk fruit in the UK could set a precedent for other regulatory bodies worldwide. Food manufacturers now have a valuable tool to meet the growing demand for healthier, sugar-reduced products, paving the way for a new era in food formulation and consumer health.

Read More

Related news

PharmaLinea’s iron supplement delivers improvements in  hemoglobin comparable to ferrous sulfate with fewer side  effects

PharmaLinea’s iron supplement delivers improvements in hemoglobin comparable to ferrous sulfate with fewer side effects

23 Feb 2026

PharmaLinea, a Slovenian developer and manufacturer of private label food supplements, has announced the completion of a clinical study evaluating its finished formulation for iron deficiency.

Read more 
LomaChelateX® – power in magnesium bisglycinate

LomaChelateX® – power in magnesium bisglycinate

12 Feb 2026

Gentle and effective: magnesium bisglycinate is setting a new standard. Through its LomaChelateX® brand, Dr. Paul Lohmann® delivers magnesium bisglycinate and a broad range of fully reacted mineral bisglycinates made in Germany.

Read more 
Fucoidan leader reports record production

Fucoidan leader reports record production

22 Jan 2026

The global leader in fucoidan science, Marinova Pty Ltd, reported record annual fucoidan production for 2025. The company's total production volume has more than doubled over the past three years.

Read more 
India Honours Ashwagandha with Commemorative  Postal Stamp at WHO Global Summit

India Honours Ashwagandha with Commemorative Postal Stamp at WHO Global Summit

6 Jan 2026

HYDERABAD, December 20, 2025 – India’s Prime Minister Mr. Narendra Modi, alongside WHO Director-General Dr. Tedros Adhanom Ghebreyesus, released a commemorative postal stamp honoring ashwagandha at the recently concluded Second WHO Global Traditional...

Read more 
PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

PharmaLinea delivers actionable 2026 insights at the first ever NutraLoop™ Summit

22 Dec 2025

PharmaLinea held its first-ever NutraLoop™ Summit this December. The virtual event featured 12 speakers from companies such as IQVIA, NHCO, Radicle Science, and BeyondBrands, who provided comprehensive insights across the scientific and commercia...

Read more 
FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

FrieslandCampina strengthens its global protein position with acquisition of Wisconsin Whey Protein

11 Dec 2025

Royal FrieslandCampina N.V. intends to acquire Wisconsin Whey Protein, a respected producer of whey protein isolates in the United States. Wisconsin Whey Protein will become part of FrieslandCampina Ingredients, a global leader in proteins and prebioti...

Read more 
dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

dsm-firmenich names ‘Frosted Star Anise’ as Flavor of the Year 2026, capturing a global desire for warmth and freshness

11 Dec 2025

Kaiseraugst (Switzerland), Maastricht (Netherlands), December 5, 2025  dsm-firmenich, innovators in nutrition, health, and beauty, announces ‘Frosted Star Anise’ as its Flavor of the Year for 2026. This...

Read more 
Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

Balchem Makes Strategic Investment in U.S. Food Ingredients Market with New Microencapsulation Manufacturing Facility

11 Dec 2025

Montvale, New Jersey, (10 December, 2025) – Balchem, a leading global manufacturer of specialty ingredients for human nutrition and health, is pleased to announce the development of a new, high-capacity man...

Read more 
Fucoidan specialist takes out top international health award

Fucoidan specialist takes out top international health award

4 Dec 2025

Marinova has been named Australia's most outstanding contributor to international health in the nation's prestigious Australian Export Awards.

Read more 
Prayon inaugurates its new SHMP production unit in Engis

Prayon inaugurates its new SHMP production unit in Engis

1 Dec 2025

Prayon inaugurates its new SHMP production unit in Engis, a major investment that strengthens its position in the food and technical phosphates market

Read more